Clinical Trial Update: Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry)

View source ↗

Summary

This completed registry study reports on the pharmacodynamic effects of cangrelor in patients with acute coronary syndrome or chronic coronary syndrome undergoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Kengreal (cangrelor)

Snippet

Sponsor: Federico II University | Conditions: Percutaneous Coronary Intervention | Status: COMPLETED